Immuron (IMRN) EBT (2016 - 2024)
Immuron (IMRN) recorded quarterly EBT of $1660259165.7 billion in Q4 2024, up 80082653894884.78% quarter-over-quarter from -$2.1 million in Q4 2023, and up 80082653894884.8% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) EBT (2016 - 2024) Analysis & Trends
Immuron's EBT history runs 9 years deep, the most recent figure standing at $1660259165.7 billion for Q4 2024.
- In Q4 2024, EBT rose 80082653894884.8% year-over-year to $1660259165.7 billion; the TTM figure through Dec 2024 stood at $1660259165.7 billion (up 31304701745637.06% YoY), while the FY2025 annual figure was -$3.4 million, up 25.69% from the prior year.
- EBT was $1660259165.7 billion for Q4 2024 at Immuron, up from -$2.1 million in the prior quarter.
- In the past five years, EBT ranged from a high of $1660259165.7 billion in Q4 2024 to a low of -$2.1 million in Q4 2023.
- Historically, EBT has averaged $276709860.9 billion across 5 years, with a median of -$648054.1 in 2020.
- The sharpest annual moves came in 2022 and 2024: EBT tumbled 14819.74% in 2022, then jumped 80082653894884.8% in 2024.
- A 5-year view of EBT shows it stood at -$57387.7 in 2020, then soared by 76.89% to -$13260.2 in 2021, then sank by 14819.74% to -$2.0 million in 2022, then decreased by 4.79% to -$2.1 million in 2023, then surged by 80082653894884.78% to $1660259165.7 billion in 2024.
- The last three EBT figures came in at $1660259165.7 billion (Q4 2024), -$2.1 million (Q4 2023), and -$1.2 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,660,259,165.67 Bn |
| Dec 31, 2023 | -2.07 Mn |
| Jun 30, 2023 | -1.24 Mn |
| Dec 31, 2022 | -1.98 Mn |
| Dec 31, 2021 | -13,260.17 |
| Dec 31, 2020 | -57,387.72 |
| Dec 31, 2019 | -15,212.27 |
| Dec 31, 2018 | -1.58 Mn |
| Dec 31, 2017 | 3.84 Mn |
| Dec 31, 2016 | 2.56 Mn |
| Jun 30, 2016 | -3.28 Mn |